Tirzepatide: The Recomp King – Optimizing Fat Distribution, Preserving & Building Lean Mass, and Delivering True Recomposition Tirzepatide (Mounjaro / Zepbound), a dual GLP-1/GIP receptor agonist with pronounced GIP activity, has redefined what is possible in the treatment of obesity, type 2 diabetes, and insulin resistance. Beyond impressive total weight loss, tirzepatide excels at improving…
Read more
Tirzepatide: The Recomp King – Superior Fat Redistribution, Lean Mass Preservation, and True Body Recomposition




















































